138 related articles for article (PubMed ID: 29033545)
21. MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest.
Wilson JM; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
J Surg Res; 2014 Oct; 191(2):280-5. PubMed ID: 24996256
[TBL] [Abstract][Full Text] [Related]
22. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis.
De Wilde K; Martens A; Lambrecht S; Jacques P; Drennan MB; Debusschere K; Govindarajan S; Coudenys J; Verheugen E; Windels F; Catrysse L; Lories R; McGonagle D; Beyaert R; van Loo G; Elewaut D
Ann Rheum Dis; 2017 Mar; 76(3):585-592. PubMed ID: 27551052
[TBL] [Abstract][Full Text] [Related]
23. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
25. Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.
Dong B; Lv G; Wang Q; Wei F; Bellail AC; Hao C; Wang G
Biochem Biophys Res Commun; 2012 Feb; 418(2):433-8. PubMed ID: 22285182
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellular carcinoma cells.
Li W; Huang X; Tong H; Wang Y; Zhang T; Wang W; Dai L; Li T; Lin S; Wu H
PLoS One; 2012; 7(10):e47040. PubMed ID: 23056571
[TBL] [Abstract][Full Text] [Related]
27. Type I and type II interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2.
Sakamoto E; Hato F; Kato T; Sakamoto C; Akahori M; Hino M; Kitagawa S
J Leukoc Biol; 2005 Jul; 78(1):301-9. PubMed ID: 15845643
[TBL] [Abstract][Full Text] [Related]
28. IL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-γ.
Li J; Zeng M; Yan K; Yang Y; Li H; Xu X
Biochem Biophys Res Commun; 2020 Feb; 522(2):525-531. PubMed ID: 31784083
[TBL] [Abstract][Full Text] [Related]
29. Combination of cetuximab and rapamycin enhances the therapeutic efficacy in hepatocellular carcinoma.
Geng J; Li X; Lang X; Qiao C; Hu M; Yang J; Feng J; Lv M
Technol Cancer Res Treat; 2014 Aug; 13(4):377-85. PubMed ID: 24325131
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of carboplatin- and quercetin-induced cell death by roscovitine is Akt dependent and p53 independent in hepatoma cells.
Sharma A; Bhat MK
Integr Cancer Ther; 2011 Dec; 10(4):NP4-14. PubMed ID: 21994207
[TBL] [Abstract][Full Text] [Related]
31. PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells.
Wang FZ; Peng-Jiao ; Yang NN; Chuang-Yuan ; Zhao YL; Liu QQ; Fei HR; Zhang JG
Toxicol Lett; 2013 Jul; 220(2):150-6. PubMed ID: 23639247
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of interferon-β on hepatocellular carcinoma HepG2 via Akt/STAT phosphorylation.
Ethiraj P; Veerappan K; Samuel S; Sivapatham S
Fundam Clin Pharmacol; 2015 Jun; 29(3):278-85. PubMed ID: 25773664
[TBL] [Abstract][Full Text] [Related]
33. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma.
Lee JH; Lee H; Yun SM; Jung KH; Jeong Y; Yan HH; Hong S; Hong SS
Cancer Lett; 2013 Feb; 329(1):99-108. PubMed ID: 23142281
[TBL] [Abstract][Full Text] [Related]
34. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
35. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity.
Ke Y; Bao T; Wu X; Tang H; Wang Y; Ge J; Fu B; Meng X; Chen L; Zhang C; Tan Y; Chen H; Guo Z; Ni F; Lei X; Shi Z; Wei D; Wang L
Biochem Biophys Res Commun; 2017 Jan; 483(1):509-515. PubMed ID: 27998773
[TBL] [Abstract][Full Text] [Related]
36. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
37. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
39. IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.
Tanaka F; Kawakami A; Tamai M; Nakamura H; Iwanaga N; Izumi Y; Arima K; Aratake K; Huang M; Kamachi M; Ida H; Origuchi T; Eguchi K
Int J Mol Med; 2005 May; 15(5):833-9. PubMed ID: 15806306
[TBL] [Abstract][Full Text] [Related]
40. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
